https://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Sanofi-et-Regeneron-font-le-point-sur-l-essai-de-phase-III-consacre-a-Kevzara-sarilumab-au-30863655/?utm_source=telegram&utm_medium=social&utm_campaign=share